Diabetes Research and Clinical Practice
Volume 87, Issue 2 , Pages 233-239, February 2010

Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients

  • Futoshi Anan

      Affiliations

    • Department of Cardiology, Oita Red Cross Hospital, Oita 870-0033, Japan
    • First Department of Internal Medicine, Oita University, Oita 870-5593, Japan
    • Corresponding Author InformationCorresponding author at: Department of Cardiology, Oita Red Cross Hospital, 3-2-37 Chiyomachi, Oita 870-0033, Japan. Tel.: +81 97 532 6181; fax: +81 97 533 1207.
  • ,
  • Takayuki Masaki

      Affiliations

    • First Department of Internal Medicine, Oita University, Oita 870-5593, Japan
  • ,
  • Hidetoshi Kikuchi

      Affiliations

    • First Department of Internal Medicine, Oita University, Oita 870-5593, Japan
  • ,
  • Tetsu Iwao

      Affiliations

    • Department of Cardiology, Oita Red Cross Hospital, Oita 870-0033, Japan
  • ,
  • Tsuyoshi Shimomura

      Affiliations

    • Department of Neurosurgery, Oita Red Cross Hospital, Oita 870-0033, Japan
  • ,
  • Yoshikazu Umeno

      Affiliations

    • Department of Endocrinology, Oita Red Cross Hospital, Oita 870-0033, Japan
  • ,
  • Nobuoki Eshima

      Affiliations

    • Department of Biostatistics, Oita University, Oita 870-5593, Japan
  • ,
  • Tetsunori Saikawa

      Affiliations

    • Department of Cardiovascular Science and School of Medicine, Oita University, Oita 870-5593, Japan
  • ,
  • Hironobu Yoshimatsu

      Affiliations

    • First Department of Internal Medicine, Oita University, Oita 870-5593, Japan

Received 18 May 2009; received in revised form 16 October 2009; accepted 26 October 2009. published online 23 November 2009.

Abstract 

The presence of white matter lesions (WML) is an important prognostic factor for the development of stroke. High-sensitivity C-reactive protein (HSCRP), which is associated with diabetes, has been flagged as a novel predictor for cerebrovascular events. This preliminary study was therefore designed to test the hypothesis that the presence of WML correlates with HSCRP and insulin resistance in type 2 diabetic patients not receiving insulin treatment.

Based on brain magnetic resonance imaging (MRI) findings, 102 type 2 diabetic patients were divided into two groups; a WML-positive group (59±6 years, mean±SD, n=40) and a WML-negative group (58±6 years, n=62). The level of blood glucose was assessed by fasting plasma glucose (FPG), fasting immunoreactive insulin (F-IRI), homeostasis model assessment (HOMA) index, and Hemoglobin A1c (HbA1c).

The body mass index was higher in the WML-positive group than in the WML-negative group (p<0.05). Plasma levels of triglycerides were higher while high-density lipoprotein cholesterol (HDL-C) was lower in the WML-positive group than in the WML-negative group (p<0.01 and p<0.005, respectively). Fasting plasma glucose (p<0.005), insulin concentrations (p<0.0001), HOMA index (p<0.0001), and HSCRP (<0.0001) levels were higher in the WML-positive group than in the WML-negative group. Multivariate logistic analysis revealed that WML was independently predicted by the high HSCRP and insulin resistance (p<0.005, p<0.0005, respectively).

The results of this preliminary study indicate that the presence of WML was associated with the high HSCRP and insulin resistance in these Japanese patients with type 2 diabetes mellitus; larger cohort studies are warranted to confirm these findings.

Keywords: High-sensitivity C reactive protein, Insulin resistance, White matter lesions, Type 2 diabetes mellitus

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(09)00465-3

doi:10.1016/j.diabres.2009.10.017

Diabetes Research and Clinical Practice
Volume 87, Issue 2 , Pages 233-239, February 2010